Skip to main content

Table 9 In silico evaluation of the toxicity profile of the selected compounds

From: UPLC–ESI–QTOF–MS profiling, antioxidant, antidiabetic, antibacterial, anti-inflammatory, antiproliferative activities and in silico molecular docking analysis of Barleria strigosa

Sr No

Compound

LD50 (mg/kg)

Predicted class

Hepatotoxic

Carcinogenic

Immunotoxic

Mutagenic

Cytotoxic

1

(3S,7E,9S)-9-Hydroxy-4,7-megastigmadien3-one 9-glucoside

4500

4

Inactive

Inactive

Inactive

Inactive

Inactive

2

(5a,8b,9b)-5,9-Epoxy-3,6-megastigma

1190

4

Active

Inactive

Active

Inactive

Inactive

3

Ixocarpalactone A

25

2

Inactive

Inactive

Active

Inactive

Active

4

Plumerubroside

10000

6

Inactive

Inactive

Active

Inactive

Active

5

Isoferulic acid

7900

6

Inactive

Inactive

Active

Inactive

Inactive